When will the side effects of Besudil/Ilak disappear and how to deal with them?

Belumosudil mesylate tablets (Belumosudil) is an oral small molecule kinase inhibitor that mainly works by inhibiting the ROCK2 (Rho-related protein kinase 2) signaling pathway, thereby regulating the immune system and improving the inflammatory and fibrotic responses in patients with chronic graft-versus-host disease (cGVHD). As a new targeted drug, Besudil may also cause certain drug-related side effects while improving disease symptoms. Common adverse reactions include gastrointestinal reactions such as diarrhea, nausea, abdominal pain, mild fatigue or weakness, and minor abnormalities in blood indicators, such as a decrease in platelets or white blood cells.

As for the duration of side effects that patients are most concerned about, clinical data show that most mild to moderate adverse reactions usually gradually reduce or disappear within a few weeks to one or two months of continuous medication. For example, gastrointestinal reactions may be obvious in the first 1-2 weeks after starting treatment, but as the body adapts to the drug, most patients will experience increased tolerance and reduced symptoms. If mild fatigue or weakness occurs, it often resolves on its own after continuing treatment for a few weeks. This self-limiting characteristic is typical of besudil as an oral targeted drug, but it still needs to be evaluated based on the patient's specific conditions.

When dealing with side effects, you should first maintain communication with the attending doctor and adjust the dose or take symptomatic treatment if necessary. For gastrointestinal symptoms, the discomfort can be relieved by eating small amounts in portions or with anti-nausea drugs; for abnormal blood indicators, it is necessary to regularly monitor changes in blood routine, and decide whether to delay medication or adjust the dose under the guidance of a doctor; for fatigue or mild headache, adequate rest and nutritional support can be ensured. Importantly, it is not recommended that patients stop taking the drug on their own or increase or decrease the dose at will, so as not to affect the therapeutic effect. Clinical practice shows that through regular monitoring and symptomatic management, most side effects are controllable and reversible.

Reference: https://www.drugs.com/pro/rezurock.html